$15.45
+
$0.06 (0.39%)
End-of-day quote: 05/21/2024
ASX:CUV
Clinuvel Pharmaceuticals Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$78.32M | $66.17M | $47.98M | $32.57M | $31.05M | $25.49M | $16.77M | $0.72M | $1.04M | $0.00M | $2.67M | $4.30M | $2.55M | $1.20M | |
| GM % | Gross Margin % |
|
90.40% | 86.02% | 85.88% | 77.58% | 98.57% | 96.27% | 96.33% | 84.22% | 85.73% | 0.00% | 77.32% | 86.83% | 62.52% | 16.04% | |
| OM | Operating Margin |
|
56.34% | 54.07% | 58.83% | 37.62% | 53.76% | 47.93% | 40.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $0.59 | $0.40 | $0.48 | $0.33 | $0.37 | $0.27 | $0.14 | $-0.32 | $-0.38 | $-0.38 | $-0.51 | $-0.48 | $-0.37 | $-0.64 |
| Div. | Dividends |
|
$0.05 | $0.04 | $0.03 | $0.03 | $0.03 | $0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
8.47% | 10.00% | 6.25% | 9.09% | 8.11% | 7.41% | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | |
| Sha. | Shares |
|
49.41m | 49.41m | 49.41m | 49.41m | 48.96m | 47.82m | 47.74m | 34.65m | 30.38m | 30.32m | 30.31m | 30.31m | 30.21m | 18.5m | |
| OCF | Operating Cash Flow |
|
$36.91M | $39.87M | $19.26M | $14.19M | $18.46M | $11.69M | $9.92M | $-10.02M | $-9.49M | $-11.78M | $-10.99M | $-7.18M | $-8.18M | $-11.40M | |
| FCF | Free Cash Flow |
|
$35.88M | $39.44M | $18.41M | $13.30M | $18.20M | $11.62M | $9.85M | $-10.03M | $-9.56M | $-11.83M | $-11.02M | $-7.40M | $-8.36M | $-11.43M | |
| FCFS | Free Cash Flow Per Share |
|
$0.73 | $0.80 | $0.37 | $0.27 | $0.38 | $0.24 | $0.21 | $-0.33 | $-0.31 | $-0.39 | $-0.36 | $-0.24 | $-0.33 | $-0.73 |
